Related Experiment Video
Updated: Dec 26, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
Weifeng Hong1,2, Hong Yuan3,2, Yujun Gu4
11Department of Medical Imaging, The First Affiliated Hospital of Guangdong Pharmaceutical University, No.19, Nong Lin Xia Road, Yuexiu District, Guangzhou, 510030 Guangdong China.
Researchers identified key immune genes in osteosarcoma, a rare bone cancer. This immune signature may help predict patient outcomes and guide new treatments for this aggressive disease.
Area of Science:
- Oncology
- Immunology
- Bioinformatics
Background:
- Osteosarcoma is an aggressive bone cancer with stagnant treatment outcomes.
- The tumor microenvironment's role in osteosarcoma is a potential therapeutic target.
Purpose of the Study:
- To identify immune-related genes associated with osteosarcoma prognosis.
- To establish a gene signature for predicting osteosarcoma patient outcomes.
Main Methods:
- Utilized ESTIMATE and CIBERSORT algorithms to analyze immune and stromal components in osteosarcoma samples.
- Identified differentially expressed genes (DEGs) and constructed protein-protein interaction (PPI) networks.
- Validated the prognostic value of a gene signature in an independent cohort and performed gene set enrichment analysis (GSEA).
Main Results:
- Identified 137 DEGs in osteosarcoma, primarily involved in neutrophil degranulation and immune response.
- Functional analysis revealed involvement in neuroactive ligand-receptor interactions and bacterial infection pathways.
- Established a significant immune-related gene signature with prognostic value.
Conclusions:
- An immune-related gene signature was developed to predict osteosarcoma outcomes.
- These findings suggest potential targets for personalized osteosarcoma treatment strategies.
More Related Videos
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021